CN
EN
Home
About us
About us
Allogeneic CAR-T cell therapy
Our motto
Our Team
What we do
Our Focus Areas
Addressing Key Challenges in Engineered T Cell Therapies
Overcoming Allogeneic CAR-T Cell Rejection
A Seasoned Executive Team at the Helm
Pipeline
Indications
Glioma
Metastases
Mesothelioma
Publications
News
Contact us
CN
/
EN
Search
About us
About us
Allogeneic CAR-T cell therapy
Our motto
Our Team
What we do
Our Focus Areas
Addressing Key Challenges in Engineered T Cell Therapies
Overcoming Allogeneic CAR-T Cell Rejection
A Seasoned Executive Team at the Helm
Pipeline
Indications
Glioma
Metastases
Mesothelioma
Publications
News
Contact us
PUBLICATIONS
2022
2023
2022
ESMO-MT026
2022ESMO MT026
2022
ESMO-MT027
2022ESMO-MT027
2023
ASCO E-POSTER
2023ASCO E-POSTER
